SCREENING OF ANTIBACTERIAL AND PHYTOCHEMICAL CONSTITUENTS OF MALVA PARVIFLORA LINN. FRUIT EXTRACTS AGAINST RESPIRATORY TRACT PATHOGENS by GAUTAM, SHIV SHANKER & SANJAY KUMAR, NAVNEET,
Research in Plant Biology 2018, 8: 13-16
doi: 10.25081/ripb.2018.v8.3567
http://updatepublishing.com/journal/index.php/ripb
Res Plant Biol • 2018 • Vol 8  13 
INTRODUCTION
Numerous microorganisms are commonly associated with 
aerosols entered into the respiratory system with air and may 
be a major factor for infections. Microbes can harbour into 
oropharynx, nasopharynx and nasal cavity, causing sore throat 
and nasal discharges, in larynx, causing hoarseness, the middle 
ear, causing otitis media with earache, causing sinusitis with 
pain in the face or head, and the eyes, causing conjunctivitis 
or keratitis [1]. Upper respiratory tract is the chief reservoir of 
opportunistic/commensals bacteria including Streptococcus 
pneumoniae, Staphylococcus aureus, Haemophilus influenzae, 
Moraxella catarrhalis and Pseudomonas aeruginosa [2, 3]. 
H. influenzae and M. catarrhalis are also responsible equally for 
Community Acquired Pneumonia (CAP) in lower respiratory 
tract. Some atypical pathogens i.e. Chlamydia pneumoniae, 
Mycoplasma pneumoniae and Legionella pneumophila are 
apparently present in CAP [4]. Even respiratory viruses 
including adenovirus, respiratory syncytial virus, influenza virus, 
human coronavirus and human rhinovirus are recently reported 
in clinical observation under respiratory infections [5].
Bacteria are capable of causing serious diseases becoming 
resistant to common antibiotics. The presence of phytochemicals 
is found in plants those played a major role in disease control 
as well as in enhancement of human health also. Investigations 
suggest that phenols, polyphenols, quinine, flavanones, 
flavonoids, tannins, coumarins, terpenoids, glycosides and 
saponins are few examples of such phytochemicals which act as 
antimicrobial, antidiarrhoeal, anthemintic etc. [6-10].
Malva genus is widespread in tropical and temperate region belongs 
to the family Malvaceae. They possess efficient role in coughing, 
intestinal infections, colitis, tonsillitis, gastroenteritis, cholesterol 
and lipid-lowering, antihypertensive, antioxidant, analgestics, 
emollient, pectoral girdle and arteriosclerosis treatment [11]. 
Malva parviflora Linn. is widely distributed in Uttarakhand. 
It is originated from the Mediterranean region of Europe and 
temperate Asia. Halvorson and Guertin [12] has been reported 
its medicinal uses and as food in many cultures since 6000 B.C. 
It prefers to grow in shade or slightly sunny area. It is an annual 
herb, commonly known as cheeseweed [13], marshmallow or little 
mallow with 40 to 60 cm in height. Flowers are white in colour. 
Plants of this family are distinguished for their antibacterial and 
antifungal activities due to the incidence of alkaloids, essential oils 
and phenolic quleoside [14, 15]. It contains wide range of cytokines 
which are valuable in treatment of inflammation [16] and aerial 
parts with high concentration of proteins [17]. M. parviflora root 
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extracts is used for the treatment of dysentery [18], leaves and 
seeds extracts for teeth infections, as laxative, expectorant and 
antitussive and in combination with Eucalyptus leaves, it helpful 
in coughing and other chest ailments [19, 20].
The literature survey showed very limited reports describing the 
antibacterial role of M. parviflora. Therefore, herein we demonstrate, 
antibacterial screening of crude extracts of M. parviflora were tested 
against selected respiratory tract pathogens.
MATERIALS AND METHODS
Plant Material
Fruits of M. parviflora were collected from Divya nursery, 
Patanjali Yogpeeth, Haridwar. Plant was identified at Botanical 
Survey of India (BSI), Dehradun and deposited a herbarium 
voucher specimen (BSD 113406). Fruits were cleaned in 
running water, dried out at room temperature and crushed in 
an electric grinder.
Preparation of Extracts
The fruit extracts were prepared with petroleum ether (PET), 
acetone (ACE), methanol (MeOH) and aqueous (H2O) by 
following standard method [21] and as explained previously [33].
Microorganisms Used
The bacterial strains namely Haemophilus influenzae (MTCC 
3826), Pseudomonas aeruginosa (MTCC 2474), Staphylococcus 
aureus (MTCC 1144), Streptococcus pyogenes (MTCC 422) and 
Streptococcus pneumoniae (MTCC 655) were purchased from 
Institute of Microbial Technology (IMTECH), Chandigarh and 
maintained at 4ºC on nutrient agar medium. For experiments, 
active bacterial cultures were prepared by transferring a loopful 
of cells from stock cultures to test tubes of Mueller Hinton 
Broth (MHB) and incubated without shakeup for 24 h at 37ºC.
Antibacterial Testing
The antibacterial activity was determined by standard method [21].
Determination of Minimum Inhibitory Concentrations 
(MICs)
Two-fold serial dilution method [22] was employed to evaluate 
the minimum inhibitory concentration (MIC).
Phytochemical Screening
The phytochemical analysis of plant extracts was done by 
following the method of Evans [23] and Scalbert [24].
RESULTS AND DISCUSSION
M. parviflora showed moderate antibacterial properties against 
selected microorganisms (Table 1). The MeOH extract of 
M. parviflora was found most active against all selected bacterial 
pathogens followed by H2O, ACE and PET. The maximum 
inhibition was found against S. pneumoniae (20.6±0.57 mm) 
and lowest against P. aeruginosa (15.3±0.28 mm) respectively. 
The moderate antibacterial activity was noted against 
S. aureus (16.6±0.57 mm), S. pyogenes (16.6±0.28 mm) and 
H. influenzae (16.0±0.50 mm). These findings can be justified 
with its medicinal uses reported by other researchers. According 
to Islam et al. [25] (2007-2010) hexane, chloroform (CHCl3) 
and ethanol (EtOH) extracts of M. parviflora displayed activity 
against four bacteria i.e. B. subtilis, E. coli, S. aureus and 
P. vulgaris. EtOH extract of leaves and seeds showed activity 
against B. Subtilis, K. pneumoniae, S. aureus, E. aerogenes 
and P. aeruginosa [26]. The ethanol extract of M. parviflora 
leaves had been reported a significant neuroprotective effect 
as by decreasing in escape latency (EL) and significant 
increase in time spent in the target quadrant (TSTQ), kind of 
improvement of learning and memory in mice [27].
In another study, three antimicrobial proteins i.e. CW-3, 
CW-4 and CW-5 were purified from seeds of M. parviflora. 
CW-3 and CW-4 proteins showed activity against Phytopthora 
infestans [28]. Some study supports M. parviflora as a good 
source for synthesis of nanomedicine [29].
The sensitivity of tested bacterial strains was quite interesting 
in respect to reference drug (erythromycin). In comparison to 
erythromycin, the activity of M. parviflora fruit extracts was 
found less efficient. Erythromycin is a macrolide antibiotic with 
broad spectrum antimicrobial role. In case of respiratory tract 
infections, it has better treatment of microorganisms especially 
for atypical organisms i.e. Mycoplasma and legionellosis [30].
The MICs were calculated for MeOH extract (Figure 1) 
and found to be varied at 3.12 - 12.5 mg/ml. The minimum 
inhibition was observed against S. pneumoniae at 3.12 mg/ml 
and maximum against P. aeruginosa at 12.5 mg/ml respectively. 
H. influenzae, S. aureus and S. pyogenes showed similar MICs 
at 6.25 mg/ml.
The preliminary phytochemical analysis for M. parviflora 
fruit extracts showed the presence of alkaloids, flavonoids, 
glycosides, steroids, terpenes, saponins and tannins in MeOH 
extract, alkaloids and flavonoids in PET extract, alkaloids, 
flavonoids, steroids, terpenes and saponins in ACE extract, 
and flavonoids, steroids, terpenes, saponins and tannins 
in H2O extract (Table 2). The results can be justified with 
other co-workers finding which concluded the presence of 
major secondary metabolites including flavonoids, alkaloids, 
glucosides, tannins, saponins in various parts of M. parviflora.
Farhan et al. [31] had showed the presence of flavonoids, 
tannins, phenols, saponins, alkaloids and resin in stem and 
leaves of M. parviflora. Abdel-Ghani et al. [11] had reported 
seven compounds including β- amyrin, α-amyrin, a mixture 
of β sitosterol and stigmasterol, cholesterol, campasterol, 
ergosterol, and β- sitosterol-O-β-D-glucoside in petroleum 
fraction, ethyl vanillin in chloroform fraction and tribuloside, a 
flavonoid glycoside, in ethyl acetate fraction. If we focus on the 
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biological properties of these phytoconstituents, a wide range 
of activity can be observed. Phytochemicals are responsible for 
colour, odour etc. and bearing protective or disease preventive 
properties. They are accountable for some other properties 
including antioxidant activity, hormonal action, enzymatic 
activity, interference with DNA replication, antimicrobial 
activity etc. [32].
CONCLUSION
In conclusion, M. parviflora fruit extracts have moderate 
antibacterial properties against selected microorganisms. The 
bioactivity of fruit extracts was confirmed by the results of 
phytochemical analysis. This can be utilized in respiratory tract 
illnesses caused by studied microorganisms. Further, research 
should be carried out to explore the bioactive components of 
M. parviflora.
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